ArticleiLIVER2025

Immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: The critical role of subgroup analyses.

Tingfeng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.